The Emcure Pharma IPO has made a remarkable debut in the stock market, listing at a significant premium of 30%. This successful initial public offering has garnered attention from investors and industry experts alike. In an exclusive interview, Namita Thapar and Satish Mehta share insightful details about the IPO. This news update provides valuable information for individuals interested in the business world, particularly in the pharmaceutical sector.
#emcurepharma #emcurepharmaipo #ipolauch #etnow #unionbudget2024 #budget2024 #topnews #stockmarket #businessnews #sharemarketnews
Subscribe To ET Now For Latest Updates On Stocks, share market, business News, Trading, Crypto Updates | [ Ссылка ]
To Stay Updated Download the Times Now App :-
Android Google Play : [ Ссылка ]
Apple App Store : [ Ссылка ]
Social Media Links :-
Twitter - [ Ссылка ]
Facebook - [ Ссылка ]
G+ - [ Ссылка ]
Website - www.etnownews.com
Subscribe Now To Our Network Channels:-
Times Now: [ Ссылка ]
Mirror Now: [ Ссылка ]
![Русские – есть! [Чёрный ящик - 45 выпуск]](https://s2.save4k.ru/pic/0QIKFBh9QX0/mqdefault.jpg)
